Working… Menu

D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02772211
Recruitment Status : Unknown
Verified May 2016 by Dr. Revital Amiaz, Sheba Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : May 13, 2016
Last Update Posted : May 13, 2016
Teva Pharmaceuticals USA
Tel Aviv University
Information provided by (Responsible Party):
Dr. Revital Amiaz, Sheba Medical Center

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2016
Estimated Study Completion Date : January 2017